Tianlong launched a campaign to care for SMA children

Xi'an TianLong Science and Technology Co., Ltd

PR97003

 

XI'AN China, July 14, 2022 /PRNewswire=KYODO JBN/

 

Tianlong has launched a campaign together with the Spinal muscular atrophy

(SMA) care center in China (a non-profit organization for SMA), and The Second

Affiliated Hospital of Xi'an Jiaotong University to care for children with SMA

in May 2022.

 

Spinal muscular atrophy (SMA) is an inherited disease that affects nerves and

muscles, causing muscles to become increasingly weak. It mostly affects infants

and children but can also develop in adults, ranking as the first fatal genetic

disease of infants.

 

Tianlong always bears social responsibility and strives for making more people

know about the disease and helping with early detection. We want to make the

world of SMA children full of love with deeds. During the campaign, we invited

many families in Xi'an, China to join us to accompany SMA children one day. We

have also invited a professor to give a lecture on SMA treatment and help

answer concerns from parents.

 

A Day with SMA Children (PRNewsfoto/Xi'an TianLong Science and Technology Co.,

Ltd)

 

As a leading molecular diagnosis products manufacturer in China, Tianlong has

PCR reagents covering 200 kinds of disease detection, including SMA detection.

Based on the PCR melting curve method, Tianlong's Human Survival Motor Neuron 1

(SMN1) Gene Detection Kit is suitable for the auxiliary diagnosis of SMN1

patients and screening of SMN1 gene carriers. Besides PCR reagents, Tianlong

can provide an integrated PCR lab solution from the nucleic acid extractor, and

PCR systems to compatible reagents. We have helped over 80 countries in

building up healthcare systems in the COVID-19 phase. Our Nucleic acid

extractors and PCR machines have been a star in the war against COVID-19.

 

Every child is a gift to parents. They need to be nurtured with full love.

Early detection can help with early diagnosis and treatment. We hope more

people know about the rare disease and more SMA children and their families can

be seen. We will bring technology to life and provide more solutions to better

care for people globally.

 

Explore Tianlong : https://www.tlgenetech.cn/

 

Follow us on:

 

LinkedIn: https://www.linkedin.com/company/tianlongbiotech

 

Facebook:https://www.facebook.com/TianlongBiotech/

 

Twitter:https://twitter.com/TianlongBiotech

 

Contact us:

 

inquiry@medtl.com

 

SOURCE: Xi'an TianLong Science and Technology Co., Ltd

 

Image Attachments Links:

 

   Link: http://asianetnews.net/view-attachment?attach-id=425362

 

 

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中